It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Meditation is a mental training approach that can improve mental health and well-being in aging. Yet the underlying mechanisms remain unknown. The Medit-Ageing model stipulates that three mechanisms — attentional, constructive, and deconstructive — upregulate positive psycho-affective factors and downregulate negative ones. To test this hypothesis, we measured brain structural MRI and perfusion, negative and positive psycho-affective composite scores, and meditation mechanisms in 27 older expert meditators and 135 meditation-naive older controls. We identified brain and psycho-affective differences and performed mediation analyses to assess whether and which meditation mechanisms mediate their links.
Meditators showed significantly higher volume in fronto-parietal areas and perfusion in temporo-occipito-parietal areas. They also had higher positive and lower negative psycho-affective scores. Attentional and constructive mechanisms both mediated the links between brain differences and the positive psycho-affective score whereas the deconstructive mechanism mediated the links between brain differences and the negative psycho-affective score.
Our results corroborate the Medit-Ageing model, indicating that, in aging, meditation leads to brain changes that decrease negative psycho-affective factors and increase positive ones through relatively specific mechanisms. Shedding light on the neurobiological and psycho-affective mechanisms of meditation in aging, these findings provide insights to refine future interventions.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Normandy University, UNICAEN, INSERM, GIP Cyceron, U1237, PhIND, Neuropresage Team, Caen, France (GRID:grid.412043.0) (ISNI:0000 0001 2186 4076)
2 University College London, Division of Psychiatry, Faculty of Brain Sciences, London, UK (GRID:grid.83440.3b) (ISNI:0000 0001 2190 1201)
3 Friedrich-Schiller-Universität Jena, Developmental Psychology, Jena, Germany (GRID:grid.9613.d) (ISNI:0000 0001 1939 2794); Technische Universität Dresden, Biological Psychology, Faculty of Psychology, Dresden, Germany (GRID:grid.4488.0) (ISNI:0000 0001 2111 7257)
4 University of Liège, GIGA-CRC In Vivo Imaging, Liège, Belgium (GRID:grid.4861.b) (ISNI:0000 0001 0805 7253); University of Liège, Psychology and Neuroscience of Cognition Research Unit, Liège, Belgium (GRID:grid.4861.b) (ISNI:0000 0001 0805 7253)
5 CHU de Caen, Service de Neurologie, Caen, France (GRID:grid.411149.8) (ISNI:0000 0004 0472 0160)
6 Normandy University, UNICAEN, INSERM, U1237, Institut Blood & Brain @ Caen, Cyceron, PhIND “Physiopathology and Imaging of Neurological Disorders”, Caen, France (GRID:grid.417831.8) (ISNI:0000 0004 0640 679X); CHU Caen-Normandie, Département de Recherche Clinique, Caen, France (GRID:grid.411149.8) (ISNI:0000 0004 0472 0160)
7 INSERM U1028, CNRS UMR5292, Lyon 1 University, Lyon Neuroscience Research Center, Lyon, France (GRID:grid.461862.f) (ISNI:0000 0004 0614 7222)
8 EUCLID/F-CRIN Clinical Trials Platform, Bordeaux, France (GRID:grid.412043.0)
9 Institut National de la Santé et de la Recherche Médicale, Caen, France (GRID:grid.7429.8) (ISNI:0000 0001 2186 6389)
10 University of Geneva, Geneva, Switzerland (GRID:grid.8591.5) (ISNI:0000 0001 2175 2154)
11 University College London, London, United Kingdom (GRID:grid.83440.3b) (ISNI:0000 0001 2190 1201)
12 Institut National de la Santé et de la Recherche Médicale, Paris, France (GRID:grid.7429.8) (ISNI:0000 0001 2186 6389)
13 EUCLID/F-CRIN Clinical Trials Platform, Bordeaux, France (GRID:grid.7429.8)
14 Institut National de la Santé et de la Recherche Médicale, Lyon, France (GRID:grid.7429.8) (ISNI:0000 0001 2186 6389)
15 University of Liege, Liege, Belgium (GRID:grid.4861.b) (ISNI:0000 0001 0805 7253)
16 Minerva Health & Care Communications Ltd, Andover, United Kingdom (GRID:grid.4861.b)
17 Deutsches Zentrum für Neurodegenerative Erkrankungen, Dresden, Germany (GRID:grid.424247.3) (ISNI:0000 0004 0438 0426)